ArticleScientific reports2025
Fear of disease progression and related factors among chronic disease patients attending South Wollo zone government hospitals.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence and associated factors of fear of progression in patients with heart failure in China: a scoping review.Frontiers in psychiatry · 2026Review
- Development of a PERMA-Based Intervention Program to Address Fear of Disease Progression in Systemic Lupus Erythematosus: A Delphi Consensus Study.Journal of multidisciplinary healthcare · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fear of disease progression is a common problem among patients with chronic disease. However, to the authors' knowledge, it was not studied in Ethiopia. Thus, this study aimed to assess fear of disease progression and related factors among patients with chronic disease attending South Wollo zone government hospitals, Northeast Ethiopia. Institution-based cross-sectional study design was conducted among 411 patients with chronic disease for quantitative data. For qualitative data in-depth interview were done until information saturation. The total sample size was allocated proportionally based on the number of patients in selected government hospitals. Finally, from each selected hospital, patients were selected using systematic random sampling technique. Fear of disease progression was measured using fear of progression questionnaire. A significant association was declared at p-value of < 0.05 in multivariable analysis. In this study, 40.9% (95% CI = 36.3-45.7) of patients had high fear of disease progression. Patients with heart failure, presence of comorbidities, not attending health education, poor social support, current chat use, severe depression, moderate anxiety and severe anxiety were significantly associated with high fear of disease progression. Eating sweet foods, heavy work, improper use of medication, afraid of death, stressful living conditions, shortness of breath and fatigue manifestations, afraid of comorbidity, absence of social support, drug resistance, thinking about children and depression were explained as the reasons for fear of disease progression in qualitative part of this study. Significant numbers of patients had high fear of disease progression. Therefore, policy makers, health professionals and community should give more attentions especially for those patients with the identified significant associated factors to reduce high fear of disease progression. Researchers should focus to get clear information about fear of disease progression for patients with a particular disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.